 Juan Monteverde, founder and managing partner at Monteverde Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Momenta Pharmaceuticals, Inc. MNTA or the Company Nasdaq: MNTA relating to its sale to Johnson Johnson. Under the terms of the agreement, MNTA shareholders will receive 52.50 in cash for each share of MNTA stock they own. 